MENU
+Compare
HLOSF
Stock ticker: OTC
AS OF
Sep 23 closing price
Price
$4.15
Change
+$0.05 (+1.22%)
Capitalization
447.97M

HLOSF HEALIOS K K Forecast, Technical & Fundamental Analysis

Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products... Show more

HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HLOSF with price predictions
Sep 25, 2025

HLOSF's Stochastic Oscillator reaches into overbought zone

The Stochastic Oscillator for HLOSF moved into overbought territory on September 25, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

HLOSF broke above its upper Bollinger Band on September 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HLOSF entered a downward trend on September 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 23, 2025. You may want to consider a long position or call options on HLOSF as a result. In of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLOSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (56.497) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (526.316) is also within normal values, averaging (344.769).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLOSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
World Trade Center Bldg. 15th Floor
Phone
N/A
Employees
108
Web
https://www.healios.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOJCX15.17N/A
N/A
Donoghue Forlines Momentum C
VRTPX21.70-0.06
-0.28%
Vanguard Real Estate II Index
NMUAX11.43-0.07
-0.61%
Neuberger Berman Multi-Cap Opp A
MWEMX48.55-0.54
-1.10%
MFS Global Equity R6
TGRFX7.25-0.09
-1.23%
Transamerica International Focus R6

HLOSF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLOSF has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HLOSF jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
ORKA - HLOSF
62%
Loosely correlated
-1.44%
PCVX - HLOSF
39%
Loosely correlated
-2.07%
CYYNF - HLOSF
39%
Loosely correlated
N/A
FHTX - HLOSF
23%
Poorly correlated
-4.48%
DMAC - HLOSF
22%
Poorly correlated
-0.15%
More